[Implementation of a new emergency room protocol at a University Medical Center in Germany: basis for improved flow of information, adequate quality management and scientific assessment]. / Implementierung eines neuen Schockraumprotokolls an einem Universitätsklinikum in Deutschland: Grundlage für einen verbesserten Informationsfluss, adäquates Qualitätsmanagement und wissenschaftliche Auswertungen.

BACKGROUND: After analyzing the existing documentation protocol for the emergency room (ER), the department of anesthesiology of the Medical University of Göttingen (UMG) developed a new department-specific ER protocol. AIM: The objective was to improve the flow of patient information from the preclinical situation through the emergency room to the early inpatient period. With this in mind a new emergency protocol was developed that encompasses the very heterogeneic patient collective in the ER as well as forming a basis for quality management and scientific investigation, taking user friendliness and efficiency into consideration. MATERIAL AND METHODS: A strategical development of a new emergency room protocol is represented, which was realized using a self-developed 8-step approach. Technical support and realization was carried out using the Scribus 1.4.2 open source desktop and GIMP 2.8.4 GNU image manipulation graphic programs. RESULTS: The new emergency room protocol was developed based on scientific knowledge and defined targets. The following 13 sections represent the contents of the new protocol: general characteristics, emergency event, initial findings and interventions, vital parameters, injury pattern, vascular access, hemodynamics, hemogram/blood gas analysis (BGA), coagulopathy, diagnostics, emergency interventions, termination of ER treatment and final evaluation. CONCLUSION: The structured and elaborated documentation was limited to the target of two sides and succeeds in incorporating trauma patients as well as non-trauma patients in the ER.

Cerebral inflammatory response during and after cardiac surgery.

BACKGROUND AND OBJECTIVE: Neurological dysfunction is a common problem after cardiac surgery with cardiopulmonary bypass (CPB). Cerebral ischaemia associated with the use of CPB may result in a release of neuronal-ischaemic markers and a subsequent cerebral inflammatory response which may additionally release inflammatory cytokines. In order to locate the origin and to quantify the release of neuronal-ischaemic markers and cytokines we investigated arterial-cerebral venous concentration gradients during and after CPB in a clinical setting. METHODS: In twenty-five patients scheduled for coronary artery bypass grafting surgery we measured the plasma concentration of neuron-specific enolase, S-100beta protein as well as interleukins (IL) IL-6, IL-8 and IL-10 from arterial and cerebral venous blood samples prior to surgery (baseline), during hypothermic CPB at 32 degrees C, after termination of bypass, as well as 2, 4 and 6 h after admission to the intensive care unit. RESULTS: Arterial-cerebral venous concentration gradients of neuron-specific enolase, S-100beta, IL-6, IL-8 and IL-10 were neither detectable during nor after CPB. Compared to the baseline period, S-100beta and neuron-specific enolase significantly increased during hypothermic CPB. After termination of CPB, neuronal-ischaemic markers as well as cytokines were increased and remained elevated during the investigated time course without reaching baseline values. CONCLUSIONS: Although we found an overall increase in plasma concentrations of neuronal-ischaemic markers, IL-6, IL-8 and IL-10 during and after CPB, arterial-cerebral venous gradients were not detectable for any of these parameters. Our results suggest that the increase of investigated parameters associated with the use of CPB are not primarily caused by a cerebral inflammatory response but rather reflect a release from other sources in the systemic circulation.

[Spontaneous breathing and stable hemodynamics during severe accidental hypothermia (22 degrees C)]. / Erhaltene Spontanatmung und stabile Hämodynamik trotz schwerer akzidentieller Hypothermie (22 C).

We present a case of severe accidental hypothermia (core temperature 22 degrees C) after a suicide attempt. The initial symptoms and the pre-hospital and hospital treatment are discussed. Additionally, different rewarming strategies for patients with severe accidental hypothermia are compared.

[Heat transfer by conductive warming with circulating-water mattresses]. / Wärmetransfer bei konduktiver Wärmung durch Wassermatten.

AIM OF THE STUDY: To determine the heat transfer by circulating-water mattresses placed under the back and over both legs of human volunteers. METHODS: With approval by the local ethics committee and informed consent eight minimally clothed volunteers were included in the study. Six calibrated heat flux transducers were placed on the back and additionally eight sensors were placed on both legs of each volunteer. The volunteers reclined on a circulating-water mattress (ComfortPad Plus(R), Cincinnati Sub-Zero Products Inc., Cincinnati, OH, USA) coated with gel (Granulab International, Armersfoort, Niederlande). Another circulating-water mattress (Plastipad trade mark, Cincinnati Sub-Zero Products Inc.) was placed over both legs. Both devices were heated to 41 degrees C by a hypo-hyperthermia system (Hico-Variotherm 530, Hirtz and Co. Hospitalwerk, Cologne, Germany). Heat flux data were sampled during steady-state conditions. After determination of the contact area between the mattresses and the skin, heat transfer was calculated by multiplication of the heat flux per area by the contact area. RESULTS: Heat flux per area to the back was 45.6 +/- 4.5 W m (- 2), the contact area was 0.39 +/- 0.03 m (2). This resulted in a heat transfer of 18.0 +/- 2.4 W. Heat flux per area to the legs was 24.7 +/- 4.3 W m (- 2), the contact area was 0.12 +/- 0.01 m (2). This resulted in a heat transfer of 2.9 +/- 0.6 W. CONCLUSION: The heat transfer of the circulating-water mattress to the back was much higher than the heat transfer to the legs. Nevertheless, model calculations show that conductive warming of the legs is more important for the prevention of perioperative hypothermia than conductive warming of the back, because it has a higher impact on the heat balance.

Changes of jugular venous blood temperature associated with measurements of cerebral blood flow using the transcerebral double-indicator dilution technique.

BACKGROUND AND OBJECTIVE: The transcerebral double-indicator dilution technique is a recently developed method to measure global cerebral blood flow at bedside. It is based on bolus injection of ice-cold indocyanine green dye and simultaneous recording of resulting thermo- and dye-dilution curves in the aorta and the jugular bulb. However, with this method 40 mL of ice-cold solution is administered as a bolus. Therefore, this prospective clinical study was performed to elucidate the effects of repeated administration of indicator on absolute blood temperature and on cerebral blood flow and metabolism. METHODS: The investigation was performed in nine male patients scheduled for elective coronary artery bypass grafting. Absolute blood temperature was measured in the jugular bulb and in the aorta before and after repeated measurements using the transcerebral double-indicator dilution technique. RESULTS: During the investigated time course, the blood temperature in the jugular bulb, compared to the aorta, was significantly higher with a mean difference of 0.21 degrees C. The administration of an ice-cold bolus reduced the mean blood temperature by 0.06 degrees C in the jugular bulb as well as in the aorta. After the transcerebral double-indicator dilution measurements a temperature recovery to baseline conditions was not observed during the investigated time period. Cerebral blood flow and cerebral metabolism did not change during the investigated time period. CONCLUSIONS: Repeated measurements with the transcerebral double-indicator dilution technique do not affect absolute jugular bulb blood temperatures negatively. Global cerebral blood flow and metabolism measurements remain unaltered. However, accuracy and resolution of this technique is not high enough to detect the effect of minor changes of physiological variables.

Differences among forced-air warming systems with upper body blankets are small. A randomized trial for heat transfer in volunteers.

BACKGROUND: Forced-air warming is known as an effective procedure in prevention and treatment of perioperative hypothermia. Significant differences have been described between forced-air warming systems in combination with full body blankets. We investigated four forced-air warming systems in combination with upper body blankets for existing differences in heat transfer. METHODS: After approval of the local Ethics Committee and written informed consent, four forced-air warming systems combined with upper body blankets were investigated in a randomized cross-over trial on six healthy volunteers: (1) BairHugger trade mark 505 and Upper Body Blanket 520, Augustine Medical; (2) ThermaCare trade mark TC 3003, Gaymar trade mark and Optisan trade mark Upper Body Blanket, Brinkhaus; (3) WarmAir trade mark 134 and FilteredFlow trade mark Upper Body Blanket, CSZ; and (4) WarmTouch trade mark 5800 and CareDrape trade mark Upper Body Blanket, Mallinckrodt. Heat transfer from the blanket to the body surface was measured with 11 calibrated heat flux transducers (HFTs) with integrated thermistors on the upper body. Additionally, the blanket temperature was measured 1 cm above the HFT. After a preparation time of 60 min measurements were started for 20 min. Mean values were calculated over 20 min. The t-test for matched pairs with Bonferroni-Holm-correcture for multiple testing was used for statistical evaluation at a P-level of 0.05. The values are presented as mean+/-SD. RESULTS: The WarmTouch trade mark blower with the CareDrape trade mark blanket obtained the best heat flux (17.0+/-3.5 W). The BairHugger trade mark system gave the lowest heat transfer (8.1+/-1.1 W). The heat transfer of the ThermaCare trade mark system and WarmAir trade mark systems were intermediate with 14.3+/-2.1 W and 11.3+/-1.0 W. CONCLUSIONS: Based on an estimated heat loss from the covered area of 38 W the heat balance is changed by 46.1 W to 55 W by forced-air warming systems with upper body blankets. Although the differences in heat transfer are significant, the clinical relevance of this difference is small.

Reliability of cerebral blood flow measurements by transcerebral double-indicator dilution technique.

BACKGROUND AND OBJECTIVE: The recently developed transcerebral double-indicator dilution technique has proven to be a feasible monitoring alternative to measure global cerebral blood flow at the bedside. However, the short-term repeatability of transcerebral double-indicator dilution measurements has not yet been investigated. The present study was designed to investigate the accuracy in terms of reliability for repeated transcerebral double-indicator dilution measurements to assess global cerebral blood flow during a definite carbon dioxide challenge in a clinical trial. METHODS: The investigation was performed in 10 patients scheduled for elective coronary artery bypass grafting. After induction of anaesthesia, repeated cerebral blood flow measurements using transcerebral double-indicator dilution were performed during target normocapnia, hypocapnia and hypercapnia. For transcerebral double-indicator dilution measurements, a bolus injection of ice-cold indocyanine green was administered into a central vein. The resulting thermal dye dilution curves were recorded simultaneously in the aorta and the jugular bulb using combined fibreoptic thermistor catheters. Cerebral blood flow was calculated from the mean transit times of the indicators through the brain. Additionally, transcranial Doppler sonography was simultaneously performed to measure transient changes in the cerebral blood flow velocity. RESULTS: Transcerebral double-indicator dilution measurements revealed a reasonable coefficient of repeatability with 9.1, 9.7 and 20.2 mL min-1 100 g-1 during normo-, hypo- and hypercapnic conditions, respectively. However, a total of 20% of the administered measurements had to be rejected for methodological reasons. CONCLUSIONS: Repeated measurements with the transcerebral double-indicator dilution method show a reasonable repeatability. With consideration to the limitations of the transcerebral double-indicator dilution technique, this new method proves to be a reliable monitoring tool to measure global cerebral blood flow at the bedside.

Bedside assessment of cerebral blood flow by double-indicator dilution technique.

BACKGROUND: Currently, quantitative measurement of global cerebral blood flow (CBF) at bedside is not widely performed. The aim of the present study was to evaluate a newly developed method for bedside measurement of CBF based on thermodilution in a clinical setting. METHODS: The investigation was performed in 14 anesthetized patients before coronary bypass surgery. CBF was altered by hypocapnia, normocapnia, and hypercapnia. CBF was measured simultaneously by the Kety-Schmidt inert-gas technique with argon and a newly developed transcerebral double-indicator dilution technique (TCID). For TCID, bolus injections of ice-cold indocyanine green were performed via a central venous line, and the resulting thermo-dye dilution curves were recorded simultaneously in the aorta and the jugular bulb using combined fiberoptic thermistor catheters. CBF was calculated from the mean transit times of the indicators through the brain. RESULTS: Both methods of measurement of CBF indicate a decrease during hypocapnia and an increase during hypercapnia, whereas cerebral metabolic rate remained unchanged. Bias between CBF(TCID) and CBFargon was -7.1+/-2.2 (SEM) ml x min(-1) x 100 g(-1); precision (+/- 2 x SD of differences) between methods was 26.6 ml x min(-1) x 100 g(-1). CONCLUSIONS: In the clinical setting, TCID was feasible and less time-consuming than alternative methods. The authors conclude that TCID is an alternative method to measure global CBF at bedside and offers a new opportunity to monitor cerebral perfusion of patients.

Effects of one minimum alveolar anesthetic concentration sevoflurane on cerebral metabolism, blood flow, and CO2 reactivity in cardiac patients.

UNLABELLED: We investigated the cerebral hemodynamic effects of 1 minimum alveolar anesthetic concentration (MAC) sevoflurane anesthesia in nine male patients scheduled for elective coronary bypass grafting. For measurement of cerebral blood flow (CBF), a modified Kety-Schmidt saturation technique was used with argon as an inert tracer gas. Measurements of CBF were performed before the induction of anesthesia and 30 min after induction under normocapnic, hypocapnic, and hypercapnic conditions. Compared with the awake state under normocapnic conditions, sevoflurane reduced the mean cerebral metabolic rate of oxygen by 47% and the mean cerebral metabolic rate of glucose by 39%. Concomitantly, CBF was reduced by 38%, although mean arterial pressure was kept constant. Significant changes in jugular venous oxygen saturation were absent. Hypocapnia and hypercapnia caused a 51% decrease and a 58% increase in CBF, respectively. These changes in CBF caused by variation of Paco2 indicate that cerebrovascular CO2 reactivity persists during 1 MAC sevoflurane anesthesia. IMPLICATIONS: We used a modified Kety-Schmidt saturation technique to investigate the effects of 1 minimum alveolar anesthetic concentration (MAC) sevoflurane on cerebral blood flow, metabolism, and CO2 reactivity in cardiac patients. We found that the global cerebral blood flow and global cerebral metabolic rate of oxygen remained coupled and that cerebrovascular CO2 reactivity is not impaired by the administration of 1 MAC sevoflurane.

Effects of 1 MAC desflurane on cerebral metabolism, blood flow and carbon dioxide reactivity in humans.

We investigated the cerebral haemodynamic effects of 1 MAC desflurane anaesthesia in nine male patients scheduled for elective coronary bypass grafting. For the measurement of cerebral blood flow (CBF) a modified Kety-Schmidt saturation technique with argon as inert tracer gas was used. Measurements of CBF were made before induction of anaesthesia and 30 min after induction under normocapnic, hypocapnic and hypercapnic conditions in sequence. Changes in mean arterial pressure after induction of anaesthesia and during the course of the study were minimized using norepinephrine infusion. In comparison with the awake state under normocapnic conditions, desflurane reduced mean cerebral metabolic rate of oxygen (CMRO2) by 51% and mean cerebral metabolic rate of glucose (CMRglc) by 35%. Concomitantly, CBF was significantly reduced by 22%; jugular venous oxygen saturation (SjvO2) increased from 58 to 74%. Hypo- and hypercapnia caused a 22% decrease and a 178% increase in CBF, respectively. These findings may be interpreted as the result of two opposing mechanisms: cerebral vasoconstriction induced by a reduction of cerebral metabolism and a direct vasodilator effect of desflurane. CBF alterations under variation of PaCO2 indicate that cerebrovascular carbon dioxide reactivity is not impaired by application of 1 MAC desflurane.

Use of modified fluid gelatin and hydroxyethyl starch for colloidal volume replacement in major orthopaedic surgery.

We have compared 6% hydroxyethyl starch (HES 200/0.5) with 3% modified fluid gelatin (MFG) for volume replacement in major orthopaedic surgery and studied the effects on haemodynamic state, colloid osmotic pressure, blood clotting and plasma homeostasis. Using a controlled, randomized, single-blind clinical design, we studied 46 consecutive patients undergoing major elective orthopaedic hip surgery. The two groups were comparable in age, body weight and duration of surgery. Patients were maintained haemodynamically stable using both HES and MFG over the entire study. Fluid balance and colloidal replacement volumes were comparable in both groups (median perioperative infusion volume: HES 2500 ml, MFG 2400 ml). Laboratory variables were not clinically different. We conclude that both colloidal solutions were comparable in volume efficacy and effects on plasma oncotic pressure, clotting and plasma homeostasis. In the small number of patients studied, 6% HES 200/0.5 was found to be safe when administered in amounts corresponding to the currently accepted maximum daily dose in Germany and France of 33 ml/kg body weight and 2.0 g/kg body weight, respectively.

[Measurement of human cerebrovascular circulation. Comparison of Kety-Schmidt technique with the intravenous 133-xenon clearance technique]. / Messung der menschlichen Hirndurchblutung. Vergleich der Kety-Schmidt -Technik mit der intravenösen 133Xe-Clearancetechnik.

UNLABELLED: In this study cerebral blood flow (CBF) was simultaneously measured with the Kety-Schmidt method and the intravenous 133Xe clearance technique. CBF, cerebral metabolic rate of oxygen (CMRO2), and CO2 reactivity of CBF were compared under fentanyl-midazolam anaesthesia and varying paCO2 levels. METHODS: Thirteen male patients were studied before they underwent coronary artery bypass surgery. For measurement of CBF with the Kety-Schmidt inert gas saturation technique, argon was used as indicator instead of nitrous oxide, because argon is less soluble in water and lipid such that arterial and hence organ saturation is attained earlier. Wash-in periods of 10 min were used for all measurements. For measurement of CBF with the intravenous xenon method 10 scintillation detectors placed lateral to the skull and an air detector for calculation of tracer recirculation were used. 10-15 mCi of 133Xe dissolved in physiological saline was injected via a peripheral i.v. cannula. For comparison with the Kety-Schmidt technique CBF15-values representing the flow of the grey and white matter were chosen. CBF was measured simultaneously with both methods under normocapnic (paCO2 43 +/- 3 mmHg), hypocapnic (paCO2 31 +/- 3 mmHg), and under hypercapnic (paCO2 54 +/- 4 mmHg) conditions. RESULTS: All CBF15 values obtained with the intravenous xenon method were significantly lower than the corresponding CBF-values measured with the Kety-Schmidt technique: by 36% under normocapnic, 23% under hypocapnic, and 39% under hypercapnic conditions, respectively. Hence, CMRO2 values calculated from CBF values obtained with the xenon method were reduced to about the same degree as those derived from CBF values measured with the Kety-Schmidt technique. There was no significant correlation between the CBF values of either method (y = 1.82x-8.58,r = 0.76 P = 0.357). Non-linear curve-fitting procedures yielded exponential CBF-paCO2 relationships for both methods, although the relative carbon dioxide reactivity was higher with the Kety-Schmidt technique than with the xenon method (y = 8.14 e0.039x vs y = 10,75 e0.023x). CONCLUSIONS: Most probably due to contamination with radioactivity from slowly perfused extracerebral tissues the intravenous 133Xe-clearance technique underestimates CBF, CMRO2, and cerebrovascular CO2 reactivity, at least when CBF15 values are used as flow parameters.

[The determination of total protein is not a suitable diagnosis for the treatment of hypoalbuminemia in intensive care patients]. / Die Bestimmung von Gesamteiweiss eignet sich nicht zur Diagnose der therapie-bedürftigen Hypoalbuminämie bei Intensivpatienten.

In clinical practice, the administration of supplementary albumin often depends on the measured plasma concentration of total protein (TPC). A TPC of less than 5 g/dl is generally accepted as an indication for albumin therapy, assuming an albumin concentration of less than 2.5 g/dl. However, a physiological relation between TPC and albumin cannot be expected in critically ill patients, and thus, measurement of TPC may be misleading as an indicator for the use of albumin. Therefore, we investigated the sensitivity and specificity of TPC testing for diagnosing hypoalbuminaemia requiring treatment. METHODS. In this prospective study, 210 consecutive patients were included. Protein electrophoresis was performed three times a week; the second electrophoresis was selected for evaluation. Applied statistical analysis revealed the number of positive total protein tests indicating hypoalbuminaemia requiring treatment (sensitivity) and the number of negative with tolerable reduced albumin concentrations (specificity). RESULTS. Of the investigated patients, 27.6% had normal TPCs between 6.2 and 8.0 g/dl. In 81.9% of cases an albumin concentration below 3.5 g/dl was found, while 43 patients had a concentration below 2.5 g/dl. The sensitivity and specificity of TPC measurement for the diagnosis of clinically relevant hypoalbuminaemia (albumin concentration < 2.5 g/dl) was calculated at different cutoff points for total protein. With a TPC of 6.0 g/dl, the sensitivity was 0.96 and the specificity 0.44. With a cutoff point of 5.0 g/dl, the sensitivity was reduced to 0.65 and specificity increased to 0.86. Finally, with a TPC of 4.0 g/dl sensitivity was 0.25 and specificity almost 1. CONCLUSIONS. Depending on the cutoff point for TPC, a relevant albumin requirement would frequently not be detected. In other cases, a need for albumin would be assumed from a reduced TPC even though the albumin concentration still exceeded 2.5 g/dl. Therefore, determination of TPC is not a suitable indicator of the need for albumin replacement. As a result, we suggest routine determination of albumin concentrations instead of TPC.

[Is cerebral venous oxygen saturation an indicator of cerebral circulation?]. / Ist die hirnvenöse Sauerstoffsättigung ein Mass für die zerebrale Durchblutung?

The arteriovenous oxygen content difference (avDO2) of the brain is dependent on O2 consumption (CM-RO2) and cerebral blood flow (CBF). With unchanging arterial O2 content, avDO2 is inversely related to cerebral venous O2 saturation (SO2). Measurement of SO2 in the jugular bulb not only provides information about the O2 balance of the brain, but may give an important estimation of CBF if a clinically useful correlation is proven. The aim of the present study was to verify this aspect. METHODS. Sixty-two male patients undergoing coronary revascularisation were investigated. The study was approved by the local Ethical Committee and each patient gave written informed consent on the preoperative day. At four points during the perioperative course arterial and cerebral venous SO2 and CBF were measured. Cerebral venous blood was sampled from a catheter in the superior bulb of the right internal jugular vein. CBF was measured using the argon wash-in technique. All sampled data were pooled and evaluated. RESULTS. As expected from theory, cerebral venous SO2 and avDO2 showed a close linear relationship (r = -0.892). However, only a weak hyperbolic relationship was found between cerebral venous SO2 and CBF. In addition, no direct correlation between CMRO2 and SO2 in the jugular bulb could be demonstrated. CONCLUSIONS. In this clinical study, a close relationship between cerebral venous SO2 and CBF was not found. This was primarily due to the high variability of cerebral O2 uptake. Changes in cerebral venous SO2 may therefore not be used as an estimate of perioperative changes in CBF.

A rational basis for the measurement of free phenytoin concentration in critically ill trauma patients.

Phenytoin binding to serum proteins and factors influencing protein binding were investigated in 38 critically ill trauma patients. In 24% of these patients, the free fraction of phenytoin was < or = 10%, whereas in 76%, the free phenytoin fraction was increased > 10%--up to 24%. Nonantiepileptic comedication, sex, or age had no influence on phenytoin binding in any of the 38 patients. Elevated free phenytoin fraction was found in those with hypoalbuminemia and hepatic and renal impairments. In these patients, the free phenytoin fraction should be measured routinely.